Nebula Research & Development LLC Acquires 8,892 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Nebula Research & Development LLC increased its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 47.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,576 shares of the company's stock after acquiring an additional 8,892 shares during the quarter. Nebula Research & Development LLC's holdings in Ryan Specialty were worth $1,769,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of RYAN. Rakuten Securities Inc. acquired a new stake in shares of Ryan Specialty during the 4th quarter worth approximately $27,000. Principal Securities Inc. grew its position in Ryan Specialty by 164.7% in the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after acquiring an additional 415 shares during the last quarter. Mizuho Bank Ltd. acquired a new position in Ryan Specialty during the fourth quarter worth about $49,000. Headlands Technologies LLC lifted its holdings in shares of Ryan Specialty by 2,644.8% in the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after acquiring an additional 767 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Ryan Specialty in the 4th quarter valued at approximately $54,000. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Stock Performance

RYAN stock traded down $0.37 during midday trading on Thursday, hitting $65.14. The company's stock had a trading volume of 455,101 shares, compared to its average volume of 967,856. The stock has a market cap of $17.06 billion, a price-to-earnings ratio of 94.34, a PEG ratio of 1.19 and a beta of 0.66. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock's 50-day moving average price is $70.26 and its 200 day moving average price is $68.83. Ryan Specialty Holdings, Inc. has a 1 year low of $48.85 and a 1 year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.74%. Ryan Specialty's payout ratio is presently 69.57%.

Insider Activity

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on RYAN. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. TD Cowen assumed coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective on the stock. Royal Bank of Canada dropped their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday, February 21st. Wells Fargo & Company lowered their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Finally, Barclays dropped their price target on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $75.67.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.